204 related articles for article (PubMed ID: 12561072)
1. Semi-closed hyperthermic-antiblastic peritoneal perfusion (HAPP) in the treatment of peritoneal carcinosis.
De Simone M; Barone R; Vaira M; Aghemo B; Mioli P; Franco C; Scuderi S; Costamagna D; Dei Poli M
J Surg Oncol; 2003 Feb; 82(2):138-40. PubMed ID: 12561072
[No Abstract] [Full Text] [Related]
2. Pharmacokinetics of cisplatin in semi-closed hyperthermic peritoneal perfusion (HPP) for treatment of peritoneal carcinomatosis.
Cattel L; De Simone M; Passera R; Verlengo MC; Delprino L
Anticancer Res; 2004; 24(3b):2041-5. PubMed ID: 15274398
[TBL] [Abstract][Full Text] [Related]
3. Drugs, carrier solutions and temperature in hyperthermic intraperitoneal chemotherapy.
Kusamura S; Dominique E; Baratti D; Younan R; Deraco M
J Surg Oncol; 2008 Sep; 98(4):247-52. PubMed ID: 18726886
[TBL] [Abstract][Full Text] [Related]
4. The randomized trial of cytoreductive surgery with hyperthermic intraperitoneal chemoperfusion: what it does and does not tell us.
Levine EA
Ann Surg Oncol; 2008 Oct; 15(10):2633-5. PubMed ID: 18696161
[No Abstract] [Full Text] [Related]
5. [Linitis of the colon with peritoneal carcinosis treated with cytoreductive surgery and intraperitoneal hyperthermic chemotherapy].
Salloum H; Locher C; Zerouala F; Segré S; Kassem M; Elias D; Ducreux M; Glikmanas M; Gatineau-Sailliant G
Gastroenterol Clin Biol; 2007 Jan; 31(1):68-9. PubMed ID: 17273132
[No Abstract] [Full Text] [Related]
6. Treatment of pseudomyxoma peritonei with two times--cytoreduction and hypertermic antiblastic peritoneal perfusion (HAPP).
De Simone M; Scuderi S; Vaira M; Costamagna D; Barone R; Fiorentini G; Dentico P; Caponi A; Ciaccio B; Caponi C; Ferri L; Martini E; Cantini S
J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):25-8. PubMed ID: 16767902
[TBL] [Abstract][Full Text] [Related]
7. Continued uncertainty regarding hyperthermic intraperitoneal chemotherapy in malignant peritoneal mesothelioma.
Markman M
J Clin Oncol; 2010 Aug; 28(24):e418; author reply e419. PubMed ID: 20566999
[No Abstract] [Full Text] [Related]
8. Hyperthermic intraperitoneal chemotherapy: nomenclature and modalities of perfusion.
Glehen O; Cotte E; Kusamura S; Deraco M; Baratti D; Passot G; Beaujard AC; Noel GF
J Surg Oncol; 2008 Sep; 98(4):242-6. PubMed ID: 18726885
[TBL] [Abstract][Full Text] [Related]
9. Reported impact of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on systemic toxicity.
Sugarbaker PH
Ann Surg Oncol; 2008 Jun; 15(6):1800-1; author reply 1802-3. PubMed ID: 18196342
[No Abstract] [Full Text] [Related]
10. [Intraperitoneal hyperthermic perfusion chemotherapy in recurrent ovarian cancer].
Wydra D; Emerich J
Ginekol Pol; 2002 Nov; 73(11):1044-7. PubMed ID: 12722397
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and pharmacodynamics of cisplatin after intraoperative hyperthermic intraperitoneal chemoperfusion (HIPEC).
Zeamari S; Floot B; van der Vange N; Stewart FA
Anticancer Res; 2003; 23(2B):1643-8. PubMed ID: 12820435
[TBL] [Abstract][Full Text] [Related]
12. Cyto-reductive Surgery combined with Hyperthermic Intra-peritoneal Chemotherapy for Peritoneal Surface Malignancies: current treatment and results.
Sommariva A; Pilati P; Rossi CR
Cancer Treat Rev; 2012 Jun; 38(4):258-68. PubMed ID: 21807464
[TBL] [Abstract][Full Text] [Related]
13. [New treatment of peritoneal carcinomatosis from colorectal cancer. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy].
Iversen LH; Rasmussen PC; Laurberg S
Ugeskr Laeger; 2007 Sep; 169(38):3179-81. PubMed ID: 17910824
[TBL] [Abstract][Full Text] [Related]
14. Hyperthermic intraoperative intraperitoneal chemotherapy for peritoneal carcinomatosis and sarcomatosis using a cardioplegia heat exchanger and a two-pump system: a case report.
Vocelka CR; Anderson DL; Crockett GI
Perfusion; 2000 Nov; 15(6):549-52. PubMed ID: 11131220
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of the peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IHPC): postoperative morbidity and mortality and short-term follow-up].
Minicozzi A; Borzellino G; Momo EN; Segattini C; Pitoni F; Steccanella F; De Manzoni G
Ann Ital Chir; 2008; 79(4):231-9. PubMed ID: 19093624
[TBL] [Abstract][Full Text] [Related]
16. Peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian peritoneal carcinomatosis: an argued role.
Di Giorgio A; Cardi M; Sammartino P
Gynecol Oncol; 2010 Apr; 117(1):146-7. PubMed ID: 20096922
[No Abstract] [Full Text] [Related]
17. [Treatment of peritoneal carcinomatosis with surgery and hyperthermic peroperative intraperitoneal chemotherapy (HIPEC): new aspects and validated indications].
Eveno C; Dagois S; Guillot E; Gornet JM; Pocard M
Bull Cancer; 2008 Jan; 95(1):141-5. PubMed ID: 18230580
[TBL] [Abstract][Full Text] [Related]
18. [Importance and problems of intraperitoneal chemotherapy].
Jakesz R
Wien Med Wochenschr; 1990 Apr; 140(8):199-202. PubMed ID: 2194375
[TBL] [Abstract][Full Text] [Related]
19. Is hyperthermic intraoperative peritoneal chemotherapy and systemic chemotherapy as effective as standard intraperitoneal chemotherapy: time for a prospective trial?
Edwards RP
Gynecol Oncol; 2011 Aug; 122(2):207-8. PubMed ID: 21763889
[No Abstract] [Full Text] [Related]
20. [Perspectives in the treatment of peritoneal carcinosis].
Arnaud JP
J Chir (Paris); 1997 Nov; 134(5-6):227-8. PubMed ID: 9772977
[No Abstract] [Full Text] [Related]
[Next] [New Search]
